These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 7500043)

  • 1. Bcl-XL displays restricted distribution during T cell development and inhibits multiple forms of apoptosis but not clonal deletion in transgenic mice.
    Grillot DA; Merino R; Núñez G
    J Exp Med; 1995 Dec; 182(6):1973-83. PubMed ID: 7500043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bcl-XL and Bcl-2 repress a common pathway of cell death.
    Chao DT; Linette GP; Boise LH; White LS; Thompson CB; Korsmeyer SJ
    J Exp Med; 1995 Sep; 182(3):821-8. PubMed ID: 7650488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes.
    Bouillet P; Purton JF; Godfrey DI; Zhang LC; Coultas L; Puthalakath H; Pellegrini M; Cory S; Adams JM; Strasser A
    Nature; 2002 Feb; 415(6874):922-6. PubMed ID: 11859372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BCL-XL-regulated apoptosis in T cell development.
    Chao DT; Korsmeyer SJ
    Int Immunol; 1997 Sep; 9(9):1375-84. PubMed ID: 9310841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein kinase B regulates T lymphocyte survival, nuclear factor kappaB activation, and Bcl-X(L) levels in vivo.
    Jones RG; Parsons M; Bonnard M; Chan VS; Yeh WC; Woodgett JR; Ohashi PS
    J Exp Med; 2000 May; 191(10):1721-34. PubMed ID: 10811865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. bcl-2 proto-oncogene expression during human T cell development. Evidence for biphasic regulation.
    Gratiot-Deans J; Ding L; Turka LA; Nuñez G
    J Immunol; 1993 Jul; 151(1):83-91. PubMed ID: 8326141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes.
    Sentman CL; Shutter JR; Hockenbery D; Kanagawa O; Korsmeyer SJ
    Cell; 1991 Nov; 67(5):879-88. PubMed ID: 1835668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The T cell receptor repertoire of CD4-8+ thymocytes is altered by overexpression of the BCL-2 protooncogene in the thymus.
    Tao W; Teh SJ; Melhado I; Jirik F; Korsmeyer SJ; Teh HS
    J Exp Med; 1994 Jan; 179(1):145-53. PubMed ID: 8270861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constitutive expression of Bcl-xL or Bcl-2 prevents peptide antigen-induced T cell deletion but does not influence T cell homeostasis after a viral infection.
    Petschner F; Zimmerman C; Strasser A; Grillot D; Nunez G; Pircher H
    Eur J Immunol; 1998 Feb; 28(2):560-9. PubMed ID: 9521066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive and negative selection of T cells in T-cell receptor transgenic mice expressing a bcl-2 transgene.
    Strasser A; Harris AW; von Boehmer H; Cory S
    Proc Natl Acad Sci U S A; 1994 Feb; 91(4):1376-80. PubMed ID: 8108419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential roles for Bim and Nur77 in thymocyte clonal deletion induced by ubiquitous self-antigen.
    Hu QN; Baldwin TA
    J Immunol; 2015 Mar; 194(6):2643-53. PubMed ID: 25687757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stabilized beta-catenin extends thymocyte survival by up-regulating Bcl-xL.
    Xie H; Huang Z; Sadim MS; Sun Z
    J Immunol; 2005 Dec; 175(12):7981-8. PubMed ID: 16339534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The apoptotic protease-activating factor 1-mediated pathway of apoptosis is dispensable for negative selection of thymocytes.
    Hara H; Takeda A; Takeuchi M; Wakeham AC; Itié A; Sasaki M; Mak TW; Yoshimura A; Nomoto K; Yoshida H
    J Immunol; 2002 Mar; 168(5):2288-95. PubMed ID: 11859117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immature thymocytes become sensitive to calcium-mediated apoptosis with the onset of CD8, CD4, and the T cell receptor expression: a role for bcl-2?
    Andjelić S; Jain N; Nikolić-Zugić J
    J Exp Med; 1993 Nov; 178(5):1745-51. PubMed ID: 8228820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD30 overexpression enhances negative selection in the thymus and mediates programmed cell death via a Bcl-2-sensitive pathway.
    Chiarle R; Podda A; Prolla G; Podack ER; Thorbecke GJ; Inghirami G
    J Immunol; 1999 Jul; 163(1):194-205. PubMed ID: 10384116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of Bim results in abnormal accumulation of mature CD4-CD8-CD44-CD25- thymocytes.
    Hutcheson J; Perlman H
    Immunobiology; 2007; 212(8):629-36. PubMed ID: 17869640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-Myb promotes the survival of CD4+CD8+ double-positive thymocytes through upregulation of Bcl-xL.
    Yuan J; Crittenden RB; Bender TP
    J Immunol; 2010 Mar; 184(6):2793-804. PubMed ID: 20142358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An essential role for nuclear factor kappaB in promoting double positive thymocyte apoptosis.
    Hettmann T; DiDonato J; Karin M; Leiden JM
    J Exp Med; 1999 Jan; 189(1):145-58. PubMed ID: 9874571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. bcl-x exhibits regulated expression during B cell development and activation and modulates lymphocyte survival in transgenic mice.
    Grillot DA; Merino R; Pena JC; Fanslow WC; Finkelman FD; Thompson CB; Nunez G
    J Exp Med; 1996 Feb; 183(2):381-91. PubMed ID: 8627151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of phorbol ester and calcium ionophore on human thymocytes.
    Tanahashi M; Yokoyama T; Kobayashi Y; Yamakawa Y; Maeda M; Fujii Y
    Hum Immunol; 2001 Aug; 62(8):771-81. PubMed ID: 11476900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.